Glyxambi (generic name Empagliflozin/Linagliptin) is a once-daily diabetic tablet used in conjunction with diet and exercise to help regulate blood sugar levels. This medication decreases your chance of dying from a stroke or heart attack if you have a history of heart disease as well as type 2 diabetes. This medication is a drug that combines two diabetic medications: linagliptin and empagliflozin
What is Glyxambi used for?
- This medication is used in individuals with type 2 diabetes mellitus to enhance blood sugar management in conjunction with diet and exercise.
- In people with type 2 diabetes and heart disease, this medication is also used to lower the risk of death from a heart attack, stroke, or heart failure.
Adult Dose for Diabetes Type 2:
- Take 5 mg orally once a day in the morning as an initial dosage
- In patients who tolerate treatment, 25 mg-linagliptin 5 mg once a day may be increased.
- Maximum daily dose: Glyxambi 25 mg-linagliptin 5 mg
- This is often taken first thing in the morning, with or without meals.
- Your blood sugar levels will need to be monitored on a regular basis, and you may also need to test the level of ketones in your urine. Empagliflozin can result in potentially fatal ketoacidosis (too much acid in the blood). Even if your blood sugar levels are normal, consult your doctor if a urine test reveals that you have high ketones in your urine.
Glyxambi Side Effects
Possible Side Effects of taking this medication:
- Acute kidney damage
- Pemphigoid bullous
- Fournier’s gangrene
- Hematocrit has risen.
- Serum cholesterol elevation
- Acute arthralgia
- Rashes on the skin
- Infection of the upper respiratory tract
- Infection of the urinary tract
- Before beginning this drug, inform your doctor if you have a history of renal or liver issues.
- If you have a history of pancreatitis, use it with care.
- Inquire with your doctor for a complete list of precautions that pertain to you.
Frequently Asked Questions
-Can I combine Glyxambi and Metformin?
Yes, these two can be used together. Your physician may employ this method if you require greater management to reduce your blood sugar levels.
Is there a direct link between Glyxambi & weight loss?
Yes, this medication also resulted in more weight reduction than linagliptin alone. Glyxambi resulted in an average weight reduction of 3.1 percent to 3.4 percent, compared to 0.7 percent with linagliptin alone.
-What is this medication’s drug class?
Glyxambi drug class is antidiabetic combinations. These are medications that contain two or more types of antidiabetic drugs (with separate mechanisms of action) in a single tablet or dosage. Taking only one tablet may enhance compliance and glycemic control.